Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.8810
-0.0590 (-6.28%)
At close: Jun 27, 2025, 4:00 PM
0.9399
+0.0589 (6.69%)
After-hours: Jun 27, 2025, 7:04 PM EDT
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $31.86 million as of June 27, 2025. Its market cap has decreased by -4.79% in one year.
Market Cap
31.86M
Enterprise Value
31.45M
1-Year Change
-4.79%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $31.86M, an increase of 1,692.41%. That is a compound annual growth rate of 195.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 33.68M | -22.41% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 220.36B |